Abstract
Erwinia persicinus was first described in 1990 after being isolated from a variety of fruits and vegetables, including bananas, cucumbers, and tomatoes. In 1994, it was shown to be the causative agent of necrosis of bean pods. We now report the first human isolate of E. persicinus. The strain was isolated from the urine of an 88-year-old woman who presented with a urinary tract infection. By the hydroxyapatite method, DNA from this strain was shown to be 94.5% related at 60°C and 86% related at 75°C to the type strain of E. persicinus. The biochemical profile of E. persicinus is most similar to those of Erwinia rhapontici, Pantoea agglomerans, and Enterobacter species. It is negative in tests for lysine, arginine, ornithine, dulcitol, and urea. It is motile and positive in tests for d-sorbitol and sucrose. It is susceptible to the expanded-spectrum cephalosporins, aminoglycosides, and fluoroquinolones, but it is resistant to ampicillin, ticarcillin, and cefazolin.
Erwinia persicinus is a plant pathogen that was described by Hao et al. (6) in 1990. These first five strains were isolated from tomatoes (n = 3), cucumber (n = 1), and banana (n = 1). In 1994, Brenner et al. (3) reported that E. persicinus was a senior subjective synonym for “Erwinia nulandii,” an organism that was pathogenic for bean pods and seeds. There are no reports in the literature of human or animal isolates of E. persicinus.
A computer-based program at the Centers for Disease Control and Prevention aids in the identification of isolates that are submitted from state public health laboratories. When the conventional biochemical reactions for a given isolate are entered into the program, the program searches the database and returns a listing of the 50 most closely related isolates that it contains. When the reactions from this organism were entered, three of the first six strains on the list were the hybridized E. persicinus strains of Hao et al. (6); two were strains, identified in this paper, which had previously been reported as “unidentified.”
In this paper, we report the first human isolate of E. persicinus and an additional food isolate.
Bacterial strains.
The strains used in this study are listed in Table 1. All were maintained at −70°C in defibrinated sheep blood. All strains were passed twice on Trypticase soy agar with 5% sheep blood (Becton Dickinson Microbiology Systems, Sparks, Md.) before being used.
TABLE 1.
Strain | Source | Sender | % Relatedness of strain 9108-82T
|
||
---|---|---|---|---|---|
At 60°C | Da | At 75°C | |||
Erwinia persicinus CDC 9108-82T (ATCC 35998T, HK 204T) | Tomato | K. Komagata, Japan | 100 | 0.0 | 100 |
E. persicinus CDC 9107-82 (HK 203) | Tomato | K. Komagata, Japan | 100 | 1.5 | 98 |
E. persicinus CDC 9109-82 (HK 205) | Tomato | K. Komagata, Japan | 97 | 1 | 91 |
E. persicinus CDC 9106-82 (HK 201) | Cucumber | K. Komagata, Japan | 88 | 6.0 | 79 |
E. persicinus CDC 9105-82 (HK 200) | Banana | K. Komagata, Japan | 81 | 5.0 | 76 |
E. persicinus CDC 4073-83 | Urine | Texas State Health Department | 95 | 3.5 | 86 |
E. persicinus CDC 839-82 | Tuna fish | F. Untermann, Germany | 93 | 3.5 | 87 |
E. rhapontici ATCC 29283T | 62 | 10 | |||
E. rhapontici ER 106 | 50 | 10 | |||
P. agglomerans 5422-69 | 49 | 10.5 |
D, divergence, calculated to the nearest 0.5%.
Media and biochemicals.
The biochemical tests were performed on conventional media by the methods of Ewing (4) and by using some of the modifications described by Farmer et al. (5) and by Hickman and Farmer (7). Incubations were at 35°C, and test results were read at 24 h, 48 h, and 7 days, unless otherwise noted. Commercially available media were used whenever possible.
Antimicrobial susceptibility.
Antimicrobial susceptibility profiles were determined for seven strains by the Kirby-Bauer disk diffusion method (8). MICs were determined by using a broth microdilution method and cation-supplemented Mueller-Hinton broth (9).
DNA methods.
The preparation, isolation, and purification of labeled and unlabeled DNA, the method used for DNA reassociation, and the method used to separate single-stranded and double-stranded DNAs on hydroxyapatite have been described elsewhere (1, 2). The DNAs were labeled enzymatically in vitro with [32P]dCTP by using a nick-translation reagent kit (Bethesda Research Laboratories, Inc., Gaithersburg, Md.) as directed by the manufacturer.
Results and discussion.
Labeled DNA from E. persicinus 9108-82T was shown to be 81 to 100% related (average, 87%) to unlabeled DNA from four other confirmed E. persicinus strains tested in 60°C reactions (Table 1). Divergence within the related sequences averaged 3%, and the degree of relatedness in reactions at 75°C was 76 to 98% (average, 86%). E. persicinus was 62% related to the type strain of Erwinia rhapontici, 50% related to a second E. rhapontici strain, and 49% related to Pantoea agglomerans. The percent divergence to these three strains was 10.0 to 10.5. The degree of relatedness of labeled DNA from E. persicinus 9108-82 to that of the human strain (strain 4073-83) was 95% at 60°C, with 3.5% divergence, and 86% at 75°C. The type strain showed a similar level of relatedness to the strain isolated from tuna (strain 839-82). These relatedness values leave no doubt that the human and tuna strains are E. persicinus.
The biochemical profiles of the two newly identified strains are characteristic of the profiles found for E. persicinus strains (Table 2). Reactions that differ from those of the type strain include the methyl red, Voges-Proskauer, Simmons citrate, rhamnose, esculin, melibiose, and galactose reactions. Partial differentiation from other Enterobacter species, E. rhapontici, and Pantoea species is presented in Table 3. Accurate identification of E. persicinus in the clinical laboratory may not be possible without the use of the extended set of conventional biochemicals listed in Table 2. Hao et al. (6) reported that all five strains in their study produced a water-soluble pink pigment when grown on peptone yeast agar supplemented with 1% glucose at 20, 25, and 30°C. Of the seven strains that we studied, strains 9108-82T and 4073-83 produced pigment at 25°C and strain 9109-82 produced pigment at both 25 and 30°C on this same medium.
TABLE 2.
Testa | Cumulative % positive at the following times:
|
Reaction of ATCC 35998Tb | ||
---|---|---|---|---|
24 h | 48 h | 7 days | ||
Indole production | 43 | − | ||
Methyl red | 57 | + | ||
Voges-Proskauer | 57 | − | ||
Citrate, Simmons | 0 | 29 | 57 | +7 |
H2S production (triple sugar iron) | 0 | 0 | 0 | − |
Urea, Christensen | 0 | 0 | 0 | − |
Phenylalanine deaminase | 0 | 0 | 0 | − |
Lysine, Moeller | 0 | 0 | 0 | − |
Arginine, Moeller | 0 | 0 | 0 | − |
Ornithine, Moeller | 0 | 0 | 0 | − |
Motility | 100 | 100 | 100 | + |
Gelatin hydrolysis (22°C) | 0 | 0 | 0 | − |
Growth in KCN | 0 | 0 | 0 | − |
Malonate utilization | 14 | 100 | 100 | +2 |
d-Glucose | ||||
Acid production | 100 | 100 | 100 | + |
Gas production | 0 | 0 | 0 | − |
Acid production from: | ||||
d-Adonitol | 0 | 0 | 0 | − |
l-Arabinose | 57 | 86 | 100 | +2 |
d-Arabitol | 0 | 0 | 0 | − |
Cellobiose | 100 | 100 | 100 | + |
Dulcitol | 0 | 0 | 0 | − |
Erythritol | 0 | 0 | 0 | − |
d-Galactose | 29 | 43 | 71 | − |
Glycerol | 0 | 0 | 0 | − |
i(myo)-Inositol | 0 | 14 | 29 | +7 |
Lactose | 14 | 14 | 14 | − |
Maltose | 0 | 0 | 0 | − |
d-Mannitol | 100 | 100 | 100 | + |
d-Mannose | 100 | 100 | 100 | + |
Melibiose | 43 | 43 | 43 | − |
α-Methyl-d-glucoside | 0 | 0 | 0 | − |
Raffinose | 71 | 71 | 71 | + |
l-Rhamnose | 0 | 43 | 71 | +3 |
Salicin | 100 | 100 | 100 | + |
d-Sorbitol | 100 | 100 | 100 | + |
Sucrose | 100 | 100 | 100 | + |
Trehalose | 86 | 100 | 100 | + |
d-Xylose | 0 | 0 | 0 | − |
Esculin hydrolysis | 14 | 71 | 100 | +7 |
Mucate, acid production | 0 | 0 | 0 | − |
Tartrate, Jordan | 0 | 0 | 100 | +7 |
Acetate utilization | 0 | 0 | 14 | − |
Lipase (corn oil) | 0 | 0 | 0 | − |
DNase (25°C) | 0 | 0 | 0 | − |
NO3−→NO2− | 100 | + | ||
Oxidase | 0 | − | ||
ONPGc | 100 | 100 | 100 | + |
Hydrogen sulfide (PIAd) | 0 | 0 | 0 | − |
Tyrosine clearing | 0 | 0 | 0 | − |
Incubation was at 35°C unless otherwise specified.
Symbols: −, negative; +, positive. The superscript number indicate the days on which the reaction became positive.
ONPG, o-nitrophenyl-β-d-galactopyranoside.
PIA, peptone iron agar.
TABLE 3.
Species | % Reactions positive in tests for the followinga:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Lysine, Moeller | Urea | Motility | Methyl red | Lactose | Sucrose | d-Sorbitol | Raffinose | Melibiose | α-Methyl-d-glucoside | Dulcitol | Esculin | |
Erwinia persicinus | 0 | 0 | 99 | 57 | 14 | 100 | 100 | 71 | 43 | 0 | 0 | 71 |
Erwinia rhapontici | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 100 | 100 | 0 | 0 | 100 |
Enterobacter aerogenes | 93 | 0 | 80 | 18 | 96 | 98 | 98 | 98 | 96 | 92 | 13 | 97 |
Enterobacter amnigenus biogroup 1 | 0 | 0 | 93 | 7 | 79 | 100 | 7 | 100 | 100 | 57 | 0 | 91 |
Enterobacter amnigenus biogroup 2 | 0 | 0 | 100 | 65 | 35 | 0 | 100 | 0 | 100 | 100 | 0 | 100 |
Enterobacter asburiae | 0 | 72 | 1 | 100 | 75 | 100 | 99 | 71 | 5 | 95 | 0 | 92 |
Enterobacter cancerogenus | 0 | 2 | 99 | 4 | 10 | 2 | 1 | 0 | 1 | 2 | 0 | 88 |
Enterobacter cloacae | 0 | 73 | 93 | 18 | 68 | 97 | 94 | 90 | 84 | 85 | 14 | 47 |
Enterobacter dissolvens | 0 | 100 | 0 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 0 | 100 |
Enterobacter gergoviae | 91 | 93 | 91 | 6 | 53 | 99 | 3 | 95 | 94 | 1 | 0 | 98 |
Enterobacter hormaechei | 0 | 86 | 55 | 9 | 21 | 100 | 3 | 0 | 0 | 83 | 86 | 0 |
Enterobacter intermedium | 0 | 0 | 90 | 100 | 100 | 70 | 100 | 100 | 100 | 100 | 90 | 100 |
Enterobacter nimipressuralis | 0 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 100 | 100 | 1 | 100 |
Enterobacter sakazakii | 0 | 1 | 95 | 3 | 99 | 100 | 1 | 99 | 100 | 96 | 8 | 100 |
Pantoea agglomerans | 0 | 10 | 84 | 48 | 39 | 80 | 27 | 30 | 32 | 7 | 11 | 63 |
Pantoea ananas | 0 | 0 | 100 | 0 | 100 | 100 | 80 | 100 | 100 | 0 | 0 | 20 |
Pantoea dispersa | 0 | 0 | 100 | 83 | 8 | 92 | 8 | 0 | 0 | 0 | 0 | 8 |
Results were obtained as positive reactions on conventional media incubated at 35°C for 48 h.
Strain 4073-83 was isolated from the urine of an 88-year-old female who presented with a urinary tract infection. The clinical history of the patient was extremely sparse; however, she had a history of atherosclerotic coronary vascular disease with congestive heart failure, hypertension, and diabetes mellitus. Her diagnoses also included a lower leg hematoma and stasis dermatitis. Her medications included indomethacin (Indocin; 25 mg three times daily [t.i.d.]), methyldopa (Aldomet; 250 mg t.i.d.), chlorpropamide (Diabinese; 250 mg daily), dipyridamole (Persantine; 25 mg t.i.d.), digoxin (Lanoxin; 0.25 mg every 3rd day), hydrochlorothiazide-triamterene (Dyazide; twice daily), furosemide (Lasix; 40 mg t.i.d.), phenytoin (Dilantin; t.i.d.), and potassium chloride (Slow K; 600 mg t.i.d.) but included no antimicrobial agents. She had been receiving most of these medications for the previous 18 months. Data regarding the colony count associated with this isolate was unavailable, making its significance in this patient unclear.
Strain 839-82 was isolated from raw tuna in Berlin, Germany. The isolate produced histamine, but it is unknown if this strain was associated with a foodborne disease.
Antimicrobial susceptibility data are shown in Table 4. All seven strains are susceptible to all 23 agents tested with the exception of ampicillin, ticarcillin, and cefazolin. The susceptibilities for these last three antimicrobial agents are at the threshold of the intermediate-resistance breakpoint.
TABLE 4.
Antimicrobial agent | MIC (μg/ml)a
|
|
---|---|---|
50% | 90% | |
Ampicillin | ≥64 | ≥64 |
Piperacillin | 32 | ≥32 |
Ticarcillin | ≥128 | ≥128 |
Amoxicillin-clavulanic acid | 4 | 4 |
Cefazolin | ≥32 | ≥32 |
Cefotaxime | 1 | 1 |
Cefotetan | 1 | 1 |
Cefpodoxime | 2 | 4 |
Ceftriaxone | 1 | 4 |
Ceftazidime | 2 | 2 |
Cefuroxime | 8 | 16 |
Imipenem | 1 | 1 |
Aztreonam | 1 | 2 |
Gentamicin | ≤0.25 | ≤0.25 |
Tobramycin | ≤0.25 | ≤0.25 |
Amikacin | 1 | 1 |
Ciprofloxacin | ≤0.06 | ≤0.06 |
Ofloxacin | ≤0.25 | ≤0.25 |
Chloramphenicol | 2 | 4 |
Nalidixic acid | 1 | 4 |
Sulfisoxazole | >32 | >32 |
Tetracycline | ≤0.5 | 1 |
Trimethoprim-sulfamethoxazole | ≤0.12/2.4 | ≤0.12/2.4 |
50% and 90%, MICs at which 50 and 90% of strains are inhibited, respectively.
Data for E. persicinus are not included in the database of any commercially available identification product. If inoculated into any of these products, the isolate would most likely be identified as P. agglomerans. Such isolates should be examined further to determine whether they are E. persicinus so that the full spectrum of disease associated with this species can be further defined.
REFERENCES
- 1.Brenner D J, Grimont P A D, Steigerwalt A G, Fanning G R, Ageron E, Riddle C F. Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and three unnamed Citrobacter genomospecies. Int J Syst Bacteriol. 1993;43:645–658. doi: 10.1099/00207713-43-4-645. [DOI] [PubMed] [Google Scholar]
- 2.Brenner D J, McWhorter A C, Leete-Knutson J K, Steigerwalt A G. Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds. J Clin Microbiol. 1982;15:1133–1140. doi: 10.1128/jcm.15.6.1133-1140.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Brenner D J, Neto J R, Steigerwalt A G, Robbs C F. “Erwinia nulandii” is a subjective synonym of Erwinia persicinus. Int J Syst Bacteriol. 1994;44:282–284. doi: 10.1099/00207713-44-2-282. [DOI] [PubMed] [Google Scholar]
- 4.Ewing W H. Edwards and Ewing’s identification of Enterobacteriaceae. 4th ed. New York, N.Y: Elsevier; 1986. [Google Scholar]
- 5.Farmer J J, III, Asbury M A, Hickman F W, Brenner D J the Enterobacteriaceae Study Group. Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens. Int J Syst Bacteriol. 1980;30:569–584. [Google Scholar]
- 6.Hao M V, Brenner D J, Steigerwalt A G, Kosako Y, Komagata K. Erwinia persicinus, a new species isolated from plants. Int J Syst Bacteriol. 1990;40:379–383. doi: 10.1099/00207713-40-4-379. [DOI] [PubMed] [Google Scholar]
- 7.Hickman F W, Farmer J J. Salmonella typhi: identification, antibiograms, serology, and bacteriophage typing. Am J Med Technol. 1978;44:1149–1159. [PubMed] [Google Scholar]
- 8.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobic disc susceptibility tests. Approved standard M2-A6. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1997. [Google Scholar]
- 9.National Committee for Clinical Laboratory Standards. Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1997. [Google Scholar]